Possible distribution or partnerships/ takeovers (Hypothetical only)

Starting this thread for considering who BD1 might be talking with. This is totally theoretical and done for myself and you to think and consider where the test Bard 1 is proving for commercial release  not  based on any known negotiations.

We all know from company announcements that "BARD1 is seeking commercialisation partners for our current diagnostic programs and welcomes interest from potential partners to discuss research collaboration or strategic alliance opportunities to expand the diagnostic and therapeutic potential of the BARD1 technology." "Exploring multiple partnering and corporate opportunities to deliver shareholder value"  (page 1030 November AGM presentation)

I had a quick look which I would welcome you to expand on:
OPKO Health is an opportunistic research and development company that targets large, high-growth markets. market cap NYSE 1.87B
GeneDx ( a subsidiary of above with current gene tests which would possibly marry very well with BD1 test) link to B test

China- GeneoDx Biotechnology Co. Ltd  (ADO asx just announced a distribution via them) link
UK- http://www.synlab.co.uk/

I found BIOPHARAMGUYS great  page and stopped almost stopped looking

(It is missing Synlab and GeneoDx) so it might be worth looking further. (I sent the very generous Adam Wilson details missing from his webpage) Love to put a prize up for the person than nails the eventual partner but that will be a win for all of us anyway

Enjoy and Remember this is pure speculation unlike the hard work BD1 very busy CEO and Board are doing.

Have a great day all